158 related articles for article (PubMed ID: 35892889)
1. Performance of Salivary Extracellular RNA Biomarker Panels for Gastric Cancer Differs between Distinct Populations.
Kaczor-Urbanowicz KE; Saad M; Grogan TR; Li F; Heo YJ; Elashoff D; Bresalier RS; Wong DTW; Kim Y
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892889
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW
Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497
[TBL] [Abstract][Full Text] [Related]
3. Salivary exRNA biomarkers to detect gingivitis and monitor disease regression.
Kaczor-Urbanowicz KE; Trivedi HM; Lima PO; Camargo PM; Giannobile WV; Grogan TR; Gleber-Netto FO; Whiteman Y; Li F; Lee HJ; Dharia K; Aro K; Martin Carreras-Presas C; Amuthan S; Vartak M; Akin D; Al-Adbullah H; Bembey K; Klokkevold PR; Elashoff D; Barnes VM; Richter R; DeVizio W; Masters JG; Wong DTW
J Clin Periodontol; 2018 Jul; 45(7):806-817. PubMed ID: 29779262
[TBL] [Abstract][Full Text] [Related]
4. Salivary Extracellular Vesicle-Associated exRNA as Cancer Biomarker.
Chiabotto G; Gai C; Deregibus MC; Camussi G
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31247906
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls.
Koopaie M; Ghafourian M; Manifar S; Younespour S; Davoudi M; Kolahdooz S; Shirkhoda M
BMC Cancer; 2022 Apr; 22(1):473. PubMed ID: 35488257
[TBL] [Abstract][Full Text] [Related]
6. Salivary extracellular RNA biomarkers for insulin resistance detection in hispanics.
Zhang Y; Sun J; Li F; Grogan TR; Vergara JL; Luan Q; Park MS; Chia D; Elashoff D; Joshipura KJ; Wong DTW
Diabetes Res Clin Pract; 2017 Oct; 132():85-94. PubMed ID: 28802700
[TBL] [Abstract][Full Text] [Related]
7. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer.
Shu J; Yu H; Li X; Zhang D; Liu X; Du H; Zhang J; Yang Z; Xie H; Li Z
Oncotarget; 2017 May; 8(22):35718-35727. PubMed ID: 28415698
[TBL] [Abstract][Full Text] [Related]
8. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
9. Salivary
Chen WD; Zhang X; Zhang MJ; Zhang YP; Shang ZQ; Xin YW; Zhang Y
World J Gastroenterol; 2022 Aug; 28(30):4120-4132. PubMed ID: 36157109
[TBL] [Abstract][Full Text] [Related]
10. RNA Sequencing Analysis of Salivary Extracellular RNA.
Majem B; Li F; Sun J; Wong DT
Methods Mol Biol; 2017; 1537():17-36. PubMed ID: 27924586
[TBL] [Abstract][Full Text] [Related]
11. A novel urinary microRNA biomarker panel for detecting gastric cancer.
Iwasaki H; Shimura T; Yamada T; Okuda Y; Natsume M; Kitagawa M; Horike SI; Kataoka H
J Gastroenterol; 2019 Dec; 54(12):1061-1069. PubMed ID: 31240436
[TBL] [Abstract][Full Text] [Related]
12. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
[TBL] [Abstract][Full Text] [Related]
13. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer.
Roy S; Kanda M; Nomura S; Zhu Z; Toiyama Y; Taketomi A; Goldenring J; Baba H; Kodera Y; Goel A
Mol Cancer; 2022 Feb; 21(1):42. PubMed ID: 35139874
[TBL] [Abstract][Full Text] [Related]
15. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients.
Necula L; Matei L; Dragu D; Pitica I; Neagu AI; Bleotu C; Dima S; Popescu I; Diaconu CC; Chivu-Economescu M
World J Gastroenterol; 2020 Jun; 26(22):3024-3033. PubMed ID: 32587446
[TBL] [Abstract][Full Text] [Related]
16. Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer.
Chen J; Wu L; Sun Y; Yin Q; Chen X; Liang S; Meng Q; Long H; Li F; Luo C; Xiao X
PeerJ; 2019; 7():e7002. PubMed ID: 31245174
[TBL] [Abstract][Full Text] [Related]
17. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer.
Wang S; Qin J; Ye H; Wang K; Shi J; Ma Y; Duan Y; Song C; Wang X; Dai L; Wang K; Wang P; Zhang J
Oncoimmunology; 2018; 7(8):e1452582. PubMed ID: 30221047
[TBL] [Abstract][Full Text] [Related]
18. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
19. Diversity and heterogeneity of extracellular RNA in human plasma.
Galvanin A; Dostert G; Ayadi L; Marchand V; Velot É; Motorin Y
Biochimie; 2019 Sep; 164():22-36. PubMed ID: 31108123
[TBL] [Abstract][Full Text] [Related]
20. Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation.
Cao W; Zhou D; Tang W; An H; Zhang Y
PeerJ; 2019; 7():e7025. PubMed ID: 31249732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
